Trinity Biotech Current Ratio 2010-2025 | TRIB
Trinity Biotech current ratio from 2010 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Trinity Biotech Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-03-31 | $0.04B | $0.03B | 1.17 |
| 2024-12-31 | $0.04B | $0.03B | 1.28 |
| 2024-09-30 | $0.05B | $0.03B | 1.64 |
| 2024-06-30 | $0.05B | $0.03B | 1.78 |
| 2024-03-31 | $0.05B | $0.02B | 2.02 |
| 2023-12-31 | $0.04B | $0.02B | 2.60 |
| 2023-09-30 | $0.04B | $0.01B | 3.44 |
| 2023-06-30 | $0.05B | $0.02B | 3.59 |
| 2023-03-31 | $0.06B | $0.02B | 3.61 |
| 2022-12-31 | $0.05B | $0.02B | 2.69 |
| 2022-09-30 | $0.05B | $0.02B | 3.38 |
| 2022-06-30 | $0.06B | $0.01B | 4.12 |
| 2022-03-31 | $0.06B | $0.02B | 3.66 |
| 2021-12-31 | $0.07B | $0.10B | 0.72 |
| 2021-09-30 | $0.08B | $0.10B | 0.76 |
| 2021-06-30 | $0.08B | $0.11B | 0.77 |
| 2021-03-31 | $0.09B | $0.03B | 2.77 |
| 2020-12-31 | $0.08B | $0.03B | 3.08 |
| 2020-09-30 | $0.07B | $0.02B | 3.13 |
| 2020-06-30 | $0.07B | $0.02B | 2.89 |
| 2020-03-31 | $0.07B | $0.02B | 3.06 |
| 2019-12-31 | $0.07B | $0.02B | 3.67 |
| 2019-09-30 | $0.08B | $0.03B | 3.13 |
| 2019-06-30 | $0.08B | $0.02B | 3.36 |
| 2019-03-31 | $0.09B | $0.02B | 4.30 |
| 2018-12-31 | $0.09B | $0.02B | 4.92 |
| 2018-09-30 | $0.09B | $0.02B | 4.48 |
| 2018-06-30 | $0.11B | $0.02B | 5.23 |
| 2018-03-31 | $0.11B | $0.02B | 5.03 |
| 2017-12-31 | $0.11B | $0.02B | 5.30 |
| 2017-09-30 | $0.12B | $0.02B | 5.16 |
| 2017-06-30 | $0.12B | $0.02B | 5.32 |
| 2017-03-31 | $0.13B | $0.02B | 5.98 |
| 2016-12-31 | $0.13B | $0.03B | 5.28 |
| 2016-09-30 | $0.15B | $0.02B | 7.27 |
| 2016-06-30 | $0.15B | $0.02B | 7.59 |
| 2016-03-31 | $0.16B | $0.02B | 7.86 |
| 2015-12-31 | $0.16B | $0.02B | 8.10 |
| 2015-09-30 | $0.17B | $0.02B | 8.54 |
| 2015-06-30 | $0.18B | $0.02B | 8.71 |
| 2015-03-31 | $0.07B | $0.02B | 3.42 |
| 2014-12-31 | $0.07B | $0.02B | 3.13 |
| 2014-09-30 | $0.07B | $0.02B | 4.31 |
| 2014-06-30 | $0.08B | $0.02B | 4.39 |
| 2014-03-31 | $0.07B | $0.02B | 4.33 |
| 2013-12-31 | $0.08B | $0.02B | 3.66 |
| 2013-09-30 | $0.08B | $0.02B | 3.37 |
| 2013-06-30 | $0.11B | $0.02B | 7.31 |
| 2013-03-31 | $0.11B | $0.01B | 7.84 |
| 2012-12-31 | $0.11B | $0.01B | 8.53 |
| 2012-09-30 | $0.11B | $0.01B | 8.04 |
| 2012-06-30 | $0.11B | $0.01B | 8.09 |
| 2012-03-31 | $0.11B | $0.01B | 9.15 |
| 2011-12-31 | $0.12B | $0.01B | 8.63 |
| 2011-09-30 | $0.11B | $0.01B | 9.17 |
| 2011-06-30 | $0.11B | $0.01B | 8.70 |
| 2011-03-31 | $0.10B | $0.01B | 7.44 |
| 2010-12-31 | $0.10B | $0.01B | 8.27 |
| 2010-09-30 | $0.10B | $0.01B | 7.36 |
| 2010-06-30 | $0.10B | $0.01B | 7.41 |
| 2010-03-31 | $0.07B | $0.03B | 2.61 |
| 2009-12-31 | $0.07B | $0.03B | 2.67 |
| 2009-09-30 | $0.07B | $0.03B | 2.30 |
| 2009-06-30 | $0.08B | $0.03B | 2.24 |
| 2009-03-31 | $0.07B | $0.03B | 2.14 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.028B | $0.062B |
| Trinity Biotech plc, headquartered in Bray, the Republic of Ireland, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market worldwide. The company provides two haemostasis product lines, Biopool and Amax, comprising test kits and instrumentation used for the detection of blood disorders. These products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the blood, liver and intestine. The Company is also a provider of raw materials to the life sciences industry. It also engages in the provision of engineering, financial, and management services, as well as in trading business. Trinity Biotech sells its products through its sales force, as well as through a network of distributors and strategic partners. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $230.767B | 27.06 |
| Boston Scientific (BSX) | United States | $157.318B | 37.52 |
| Stryker (SYK) | United States | $150.713B | 30.68 |
| EssilorLuxottica (ESLOY) | France | $147.808B | 0.00 |
| Medtronic (MDT) | Ireland | $118.836B | 16.76 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.610B | 0.00 |
| Haleon (HLN) | United Kingdom | $44.076B | 25.18 |
| ResMed (RMD) | United States | $43.006B | 30.76 |
| Agilent Technologies (A) | United States | $34.551B | 22.52 |
| GE HealthCare Technologies (GEHC) | United States | $34.343B | 16.14 |
| Terumo (TRUMY) | Japan | $27.701B | 32.82 |
| Koninklijke Philips (PHG) | Netherlands | $27.289B | 18.05 |
| Insulet (PODD) | United States | $23.284B | 78.01 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.337B | 13.58 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.420B | 0.00 |
| Baxter (BAX) | United States | $12.604B | 9.74 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.222B | 30.20 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $3.958B | 10.70 |
| Envista Holdings (NVST) | United States | $3.609B | 25.26 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Perrigo (PRGO) | Ireland | $3.369B | 8.42 |
| Prestige Consumer Healthcare (PBH) | United States | $3.283B | 14.57 |
| ICU Medical (ICUI) | United States | $3.164B | 21.54 |
| Haemonetics (HAE) | United States | $2.716B | 12.12 |
| LeMaitre Vascular (LMAT) | United States | $2.271B | 48.70 |
| Acuren (TIC) | United States | $2.108B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.894B | 11.92 |
| Curaleaf Holdings (CURLF) | Canada | $1.891B | 0.00 |
| AtriCure (ATRC) | United States | $1.872B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.757B | 75.45 |
| Phibro Animal Health (PAHC) | United States | $1.316B | 16.82 |
| AdaptHealth (AHCO) | United States | $1.300B | 18.48 |
| Tilray Brands (TLRY) | Canada | $1.266B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.241B | 2591.00 |
| Neogen (NEOG) | United States | $1.225B | 19.45 |
| Valneva SE (VALN) | France | $0.990B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $0.954B | 0.00 |
| InMode (INMD) | Israel | $0.936B | 8.66 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.624B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.607B | 0.00 |
| SNDL (SNDL) | Canada | $0.591B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.561B | 0.00 |
| ZimVie (ZIMV) | United States | $0.534B | 20.60 |
| Surmodics (SRDX) | United States | $0.532B | 0.00 |
| Evolus (EOLS) | United States | $0.497B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.482B | 16.60 |
| CeriBell (CBLL) | United States | $0.442B | 0.00 |
| Owens & Minor (OMI) | United States | $0.390B | 3.46 |
| Sanuwave Health (SNWV) | United States | $0.386B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.325B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.306B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.305B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.302B | 0.00 |
| Omeros (OMER) | United States | $0.299B | 0.00 |
| High Tide (HITI) | Canada | $0.290B | 0.00 |
| Brainsway (BWAY) | Israel | $0.287B | 58.46 |
| Viemed Healthcare (VMD) | United States | $0.284B | 21.50 |
| Aurora Cannabis (ACB) | Canada | $0.282B | 0.00 |
| Cerus (CERS) | United States | $0.243B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.241B | 0.00 |
| Quanterix (QTRX) | United States | $0.224B | 0.00 |
| Exagen (XGN) | United States | $0.222B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.219B | 0.00 |
| Organigram Global (OGI) | Canada | $0.214B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.195B | 16.30 |
| TriSalus Life Sciences (TLSI) | United States | $0.191B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.160B | 19.65 |
| Biote (BTMD) | United States | $0.159B | 5.28 |
| Jushi Holdings (JUSHF) | United States | $0.133B | 0.00 |
| Jin Medical (ZJYL) | China | $0.113B | 0.00 |
| MacroGenics (MGNX) | United States | $0.107B | 0.00 |
| Fonar (FONR) | United States | $0.095B | 12.19 |
| Quipt Home Medical (QIPT) | United States | $0.093B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Apyx Medical (APYX) | United States | $0.079B | 0.00 |
| Safety Shot (SHOT) | United States | $0.070B | 0.00 |
| Agape ATP (ATPC) | $0.066B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.057B | 0.00 |
| ImmuCell (ICCC) | United States | $0.055B | 32.07 |
| Veru (VERU) | United States | $0.053B | 0.00 |
| Zynex (ZYXI) | United States | $0.050B | 0.00 |
| Nephros (NEPH) | United States | $0.044B | 34.83 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 14.95 |
| Senestech (SNES) | United States | $0.023B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Allurion Technologies (ALUR) | United States | $0.017B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.016B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Sharps Technology (STSS) | United States | $0.008B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |